Current
Updated Recommendations of the Advisory Committee on Immunization Practices (ACIP) Regarding Routine Poliovirus Vaccination
MMWR, August 7, 2009; 58(30):829-30
Current
Addition of Severe Combined Immunodeficiency as a Contraindication for Administration of Rotavirus Vaccine
MMWR June 11, 2010;59(22):687-688
-
Pneumococcal
-
PPSV (Pneumococcal Polysaccharide)
Current
Updated ACIP Recommendations: Prevention of Invasive Pneumococcal Disease Among Adults Using the 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23)
MMWR, September 3, 2010; 59(34):1102-6
Current
History of Intussusception as a Contraindication for Rotavirus Vaccination
MMWR, October 21, 2011;60(41):1427-1427
-
PCV (Pneumococcal Conjugate)
-
Pneumococcal
-
PPSV (Pneumococcal Polysaccharide)
Current
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine for Adults with Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
MMWR, October 12, 2012; 61(40):816-9
-
PCV (Pneumococcal Conjugate)
-
Pneumococcal
-
PPSV (Pneumococcal Polysaccharide)
Current
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Children Aged 6–18 Years with Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
MMWR, June 28, 2013; 62(25):521-524
Current
Updated Recommendations for Use of VariZIG -- United States, 2013
MMWR, July 19, 2013; 62(28):574-6
-
PCV (Pneumococcal Conjugate)
-
Pneumococcal
-
PPSV (Pneumococcal Polysaccharide)
Current
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged >65 Years: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
MMWR, September 19, 2014; 63(37):822-825
Current
Updated Recommendations for the Use of Typhoid Vaccine — Advisory Committee on Immunization Practices, United States, 2015
MMWR, March 27, 2015;64(11):305–308,
-
HPV (Human Papillomavirus)
Current
Use of 9-Valent Human Papillomavirus (HPV) Vaccine: Updated HPV Vaccination Recommendations of the Advisory Committee on Immunization Practices
MMWR, March 27, 2015; 64(11):300-304
Current
Yellow Fever Vaccine Booster Doses: Recommendations of the Advisory Committee on Immunization Practices, 2015
MMWR, June 19, 2015; 64(23);647-650
-
PCV (Pneumococcal Conjugate)
-
Pneumococcal
-
PPSV (Pneumococcal Polysaccharide)
Current
Intervals Between PCV13 and PPSV23 Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
MMWR, September 4, 2015; 64(34):944-947
Current
Use of Vaccinia Virus Smallpox Vaccine in Laboratory and Health Care Personnel at Risk for Occupational Exposure to Orthopoxviruses—Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2015
MMWR, March 18, 2016, Vol. 65(10):257-262
-
HPV (Human Papillomavirus)
Current
Use of a 2-Dose Schedule for Human Papillomavirus Vaccination: Updated Recommendations of the Advisory Committee on Immunization Practices
MMWR, December 16, 2016; 65(49);1405-8
Current
Guidance for Assessment of Poliovirus Vaccination Status and Vaccination of Children Who Have Received Poliovirus Vaccine Outside the United States
MMWR, January 13, 2017; 66(01); 23–25
Current
Recommendations of the Advisory Committee on Immunization Practices for Use of Cholera Vaccine
MMWR May 12, 2017, 66(18);482–485
Current
Recommendations of the Advisory Committee on Immunization Practices for Use of a Third Dose of Mumps Virus-Containing Vaccine in Persons at Increased Risk for Mumps During an Outbreak
MMWR, January 12, 2018; 67(1); 33–37
Current
Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines
MMWR, January 26, 2018; 67(3); 103–108
Current
Recommendations of the Advisory Committee on Immunization Practices for Use of a Hepatitis B Vaccine with a Novel Adjuvant
MMWR, April 20, 2018; 67 (15): 455-458
-
HPV (Human Papillomavirus)
Current
Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices
MMWR August 16, 2019; 68(32): 698–702
-
PCV (Pneumococcal Conjugate)
-
Pneumococcal
-
PPSV (Pneumococcal Polysaccharide)
Current
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged 65 Years and older: Updated Recommendations of the Advisory Committee on Immunization Practices
MMWR, November 22, 2019; 68(46):1069–1075
-
Diphtheria
-
Pertussis
-
Tetanus
Current
Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccines: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2019
MMWR, January 24, 2020, Vol 69 (3);77-83
-
Diphtheria
-
Hepatitis B
-
Hib (Haemophilus Influenzae Type B)
-
Pertussis
-
Polio
-
Tetanus
Current
Licensure of a Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus influenzae Type b Conjugate, and Hepatitis B Vaccine, and Guidance for Use in Infants
MMWR, February 7, 2020, 69 (5);136-139
Current
ACIP Recommendations for Use of Recombinant Zoster Vaccine (RZV, Shingrix, GSK) in Immunocompromised Adults aged 19 years and older, US, 2022
MMWR, January 21, 2022, 71(3);80-84
Current
Use of Ebola Vaccine: Expansion of ACIP Recommendations to include two additional populations, US, 2021
MMWR, February 25, 2022, 71(8);290–292
Current
Universal Hepatitis B Vaccination in Adults Aged 19–59 Years, updated ACIP recommendations
MMWR, April 1, 2022, 71(13);477–483
Current
Use of a Modified Preexposure Prophylaxis Vaccination Schedule to Prevent Human Rabies: Recommendations of the Advisory Committee on Immunization Practices — US, 2022
MMWR, May 6, 2022, 71(18);619–627
-
Mpox (Monkeypox)
-
Smallpox
Current
Use of Jynneos (smallpox and monkeypox vaccine, live, nonreplicating) for preexposure vaccination of persons at risk for occupational exposure to orthopoxviruses: Recommendations of the Advisory Committee on Immunization Practices — US, 2022
MMWR, May 27, 2022, Vol 71
-
PCV (Pneumococcal Conjugate)
-
Pneumococcal
Current
Use of 15-Valent Pneumococcal Conjugate Vaccine Among U.S. Children: Updated Recommendations of the Advisory Committee on Immunization Practices—United States, 2022
MMWR, September 16, 2022, 71(37);1174–1181
Current
Measles, Mumps, Rubella Vaccine (PRIORIX): Recommendations of the Advisory Committee on Immunization Practices—United States, 2022
MMWR, November 18, 2022, 71 (46); 1465-1470
-
RSV (Respiratory Syncytial Virus)
Current
Use of Respiratory Syncytial Virus Vaccines in Older Adults: Recommendations of the Advisory Committee on Immunization Practices
MMWR, July 21, 2023, 72 (29); 793-801
-
RSV (Respiratory Syncytial Virus)
Current
Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices—United States, 2023
MMWR, August 25, 2023, 72(34); 920–925
-
PCV (Pneumococcal Conjugate)
-
Pneumococcal
Current
ACIP Updates: Recommendations for Use of 20-Valent Pneumococcal Conjugate Vaccine in Children ― United States, 2023
MMWR. 2023 / 72(39);1072
-
RSV (Respiratory Syncytial Virus)
Current
Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus–Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023
MMWR, October 13, 2023, 72(41);1115-1122
Current
Use of Inactivated Polio Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2023
MMWR December 8, 2023 / 72(49);1327–1330
-
Meningococcal ACWY
-
Meningococcal B
Current
Use of the Pfizer Pentavalent Meningococcal Vaccine Among Persons Aged ≥10 Years: Recommendations of the Advisory Committee on Immunization Practices ― United States, 2023
MMWR April 18, 2024 / 73(15);345–350
-
RSV (Respiratory Syncytial Virus)
Current
Use of Respiratory Syncytial Virus Vaccines in Adults Aged ≥60 Years: Updated Recommendations of the Advisory Committee on Immunization Practices— United States, 2024
MMWR August 15, 2024 / 73(32);696-702
-
Hib (Haemophilus Influenzae Type B)
Current
Use of Haemophilus influenzae Type b–Containing Vaccines Among American Indian and Alaska Native Infants: Updated Recommendations of the Advisory Committee on Immunization Practices ― United States, 2024
MMWR September 12, 2024 / 73(36);799–802
Current
Use of COVID-19 Vaccines for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024–2025
MMWR: Early Release September 10, 2024, 73
Current
Updated Recommendation for Universal Hepatitis B Vaccination in Adults Aged 19–59 Years — United States, 2024
MMWR Weekly / December 5, 2024 / 73(48);1106
Current
Use of Additional Doses of 2024–2025 COVID-19 Vaccine for Adults Aged ≥65 Years and Persons Aged ≥6 Months with Moderate or Severe Immunocompromise: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024
MMWR December 12, 2024 / 73(49);1118–1123
Current
New Dosing Interval and Schedule for the Bexsero MenB-4C Vaccine: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, October 2024
MMWR December 12, 2024 / 73(49);1124–1128
-
PCV (Pneumococcal Conjugate)
-
Pneumococcal
Current
Expanded Recommendations for Use of Pneumococcal Conjugate Vaccines among Adults aged ≥50 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024
MMWR 2025;74:1–8
Current
Prevention of Plague Recommendations of the Advisory Committee on Immunization Practices (ACIP)
MMWR December 13, 1996 / Vol. 45 / No. RR-14
Current
Poliomyelitis Prevention in the United States Updated Recommendations of the Advisory Committee on Immunization Practices (ACIP)
MMWR May 19, 2000 / Vol. 49 / No. RR-05
Current
Vaccinia (Smallpox) Vaccine Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2001
MMWR June 22, 2001 / Vol. 50 / No. RR-10
Current
Recommendations for Using Smallpox Vaccine in a Pre-Event Vaccination Program
MMWR, Recommendations and Reports, April 4, 2003, Vol. 52(RR-7)
Current
Prevention of Varicella Recommendations of the Advisory Committee on Immunization Practices (ACIP)
MMWR, June 22, 2007; 56(RR-4):1-40
Current
Human Rabies Prevention--United States, 2008: Recommendations of the Advisory Committee on Immunization Practices
MMWR, May 23, 2008; 57(RR03):1-26,28
Current
Prevention of Herpes Zoster: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
MMWR, June 6, 2008; 57(05):1-30
Current
Prevention of Rotavirus Gastroenteritis Among Infants and Children: Recommendations of the Advisory Committee on Immunization Practices
MMWR, February 6, 2009, Vol. 58 (RR-2)
-
Measles
-
Mumps
-
Rubella
-
Varicella (Chickenpox)
Current
Use of Combination Measles, Mumps, Rubella, and Varicella Vaccine--Recommendations of the Advisory Committee on Immunization Practices
MMWR, May 7, 2010; 59(RR--3):1 - 16
Current
Yellow Fever Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
MMWR, July 30, 2010; 59(RR07):1-27
-
PCV (Pneumococcal Conjugate)
-
Pneumococcal
-
PPSV (Pneumococcal Polysaccharide)
Current
Prevention of Pneumococcal Disease Among Infants and Children--Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine
MMWR, December 10, 2010; 59(RR11):1-18
Current
Prevention of Measles, Rubella, Congenital Rubella Syndrome, and Mumps, 2013 -- Summary Recommendations of the Advisory Committee on Immunization Practices (ACIP)
MMWR, June 14, 2013; 62(RR04):1-34
-
Hib (Haemophilus Influenzae Type B)
Current
Prevention and Control of Haemophilus influenzae Type b Disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP) Recommendations and Reports
MMWR, February 28, 2014; 63(RR01):1-14
-
HPV (Human Papillomavirus)
Current
Human Papillomavirus Vaccination: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
MMWR, August 29, 2014; 63(RR-5):1-30
Current
Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices
MMWR, January 12, 2018; 67 (1); 1–31
-
Diphtheria
-
Pertussis
-
Tetanus
Current
Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
MMWR, April 27, 2018; 67 (2):1-44
-
Japanese Encephalitis (JE)
Current
Japanese Encephalitis Vaccine: Recommendations of the Advisory Committee on Immunization Practices
MMWR, July 19, 2019, 68(2); 1-33
Current
Use of Anthrax Vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2019
MMWR, December 13, 2019, 68(4);1–14
Current
Prevention of Hepatitis A Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2020
MMWR, July 3, 2020, Vol 69 (5);1-38
-
Meningococcal ACWY
-
Meningococcal B
Current
Meningococcal Vaccination: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020
MMWR, September 25, 2020, Volume 69(9); 1–41
Current
Use of Ebola Vaccine: Recommendations of the Advisory Committee on Immunization Practices, U.S., 2020
MMWR, January 8, 2021,70(1);1–12
Current
ACIP Recommendations on Dengue Vaccine, US, 2021
MMWR December 17, 2021, 70(6);1–16
